What are the risk factors for kidney disease? My mother died from kidney failure a few years ago at age 75 but didn’t even ...

The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with ...

New UCLA research conducted using mouse models and human genetic data has uncovered a critical factor that determines how ...

Tirzepatide offers a promising treatment for patients with obesity, chronic kidney disease, and heart failure, improving both ...

Chronic Kidney Disease (CKD) affects approximately 15% of U.S. adults and as many as 9 in 10 with CKD are unaware they have ...

Results from the SUMMIT trial suggest that tirzepatide is as effective in preventing heart failure events in those with ...

In patients with heart failure with preserved ejection fraction and obesity, tirzepatide improved clinical outcomes compared ...

The overall rate of cardiovascular death or worsening heart failure, the trial’s primary endpoint, was higher in the 60% of study participants who also had chronic kidney disease. However, tirzepatide ...

The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart ...